XRF Scientific Balance Sheet Health
Financial Health criteria checks 6/6
XRF Scientific has a total shareholder equity of A$55.5M and total debt of A$2.9M, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are A$68.2M and A$12.7M respectively. XRF Scientific's EBIT is A$13.7M making its interest coverage ratio 47.8. It has cash and short-term investments of A$12.0M.
Key information
5.3%
Debt to equity ratio
AU$2.93m
Debt
| Interest coverage ratio | 47.8x |
| Cash | AU$12.05m |
| Equity | AU$55.54m |
| Total liabilities | AU$12.69m |
| Total assets | AU$68.23m |
Recent financial health updates
Here's Why XRF Scientific (ASX:XRF) Can Manage Its Debt Responsibly
Nov 13
XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly
May 24XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly
Oct 19We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease
May 12Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?
Apr 19Recent updates
Here's Why XRF Scientific (ASX:XRF) Can Manage Its Debt Responsibly
Nov 13Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report
Aug 21XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly
May 24Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?
Feb 12Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)
Jan 18Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention
Oct 05XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033
Sep 19XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's
Aug 28Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?
Aug 22Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?
Feb 01XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly
Oct 19We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease
May 12XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue
Apr 21Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?
Oct 01XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital
May 18Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?
Apr 19An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued
Mar 17XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues
Mar 01Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?
Feb 17
Our View On XRF Scientific's (ASX:XRF) CEO Pay
Jan 27Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?
Jan 12XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 23XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price
Dec 10The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come
Nov 25Financial Position Analysis
Short Term Liabilities: XRF's short term assets (A$39.2M) exceed its short term liabilities (A$10.4M).
Long Term Liabilities: XRF's short term assets (A$39.2M) exceed its long term liabilities (A$2.2M).
Debt to Equity History and Analysis
Debt Level: XRF has more cash than its total debt.
Reducing Debt: XRF's debt to equity ratio has reduced from 12.5% to 5.3% over the past 5 years.
Debt Coverage: XRF's debt is well covered by operating cash flow (275.8%).
Interest Coverage: XRF's interest payments on its debt are well covered by EBIT (47.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:30 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
XRF Scientific Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Cameron Bell | Canaccord Genuity |